LACK OF VESICANT INJURY FOLLOWING EXTRAVASATION OF LIPOSOMAL DOXORUBICIN

被引：45
作者：
MADHAVAN, S [1 ]
NORTHFELT, DW [1 ]
机构：
[1] UNIV CALIF SAN FRANCISCO,DIV HEMATOL ONCOL,AIDS ONCOL PRACTICE,SAN FRANCISCO,CA 94143
来源：
JOURNAL OF THE NATIONAL CANCER INSTITUTE | 1995年 / 87卷 / 20期
关键词：
D O I：
10.1093/jnci/87.20.1556
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1556 / 1557
页数：2
相关论文
共 11 条
[1]   SUBCUTANEOUS ADMINISTRATION OF LIPOSOMES - A COMPARISON WITH THE INTRAVENOUS AND INTRAPERITONEAL ROUTES OF INJECTION [J].
ALLEN, TM ;
HANSEN, CB ;
GUO, LSS .
BIOCHIMICA ET BIOPHYSICA ACTA, 1993, 1150 (01) :9-16
[2]  
Boyle D M, 1995, Oncol Nurs Forum, V22, P57
[3]  
COHEN MH, 1979, CANCER TREAT REP, V63, P1003
[4]  
DORR RT, 1989, CANCER, V64, P2462, DOI 10.1002/1097-0142(19891215)64:12<2462::AID-CNCR2820641211>3.0.CO
[5]  
2-9
[6]  
DORR RT, 1994, CANCER CHEMOTHERAPY, P397
[7]   TREATMENT METHODS FOR EXTRAVASATIONS OF CHEMOTHERAPEUTIC-AGENTS - A COMPARATIVE-STUDY [J].
LOTH, TS ;
EVERSMANN, WW .
JOURNAL OF HAND SURGERY-AMERICAN VOLUME, 1986, 11A (03) :388-396
[8]  
RUDOLPH R, 1976, CANCER, V38, P1087, DOI 10.1002/1097-0142(197609)38:3<1087::AID-CNCR2820380308>3.0.CO
[9]  
2-X
[10]  
RUDOLPH R, 1979, CANCER TREAT REP, V63, P529
12